Literature DB >> 15629620

A practical approach to thermography in a hyperthermia/magnetic resonance hybrid system: validation in a heterogeneous phantom.

Johanna Gellermann1, Waldemar Wlodarczyk, Hildegard Ganter, Jacek Nadobny, Horst Fähling, Martin Seebass, Roland Felix, Peter Wust.   

Abstract

PURPOSE: This study investigates the feasibility and accuracy of noninvasive magnetic resonance (MR) monitoring for a system that includes a multiantenna applicator for part-body hyperthermia (SIGMA-Eye applicator, BSD-2000/3D) and a 1.5 Tesla MR tomograph (Siemens Magnetom Symphony).
METHODS: A careful electrical decoupling enabled simultaneous operation of both systems, the hyperthermia system (100 MHz, up to 1600 W) and the MR tomograph (63.9 MHz). We used the phase data sets of a gradient echo sequence (long echo time TE = 20 ms) according to the proton frequency shift (PFS) method to determine MR temperature changes. Data postprocessing and visualization was conducted in the software platform AMIRA-HyperPlan. Heating was evaluated in an elliptical Lucite cylinder of 50 cm length filled with tissue-equivalent agarose and a skeleton made from low-dielectric material to simulate the heterogeneity of a real patient. Multiple catheters were included longitudinally for direct thermometry (using Bowman high-impedance thermistors). The phantom was positioned in the 24-antenna applicator SIGMA-Eye employing the integrated water bolus (filled with deionized water) both for coupling the radiated power into the lossy medium and to enable a correction procedure based on direct temperature measurements.
RESULTS: In eight phantom experiments we monitored the heating in the applicator not only by repetitive acquisition of three-dimensional MR datasets, but also by measuring temperature-time curves directly at selected spatial positions. For the correction, we specified regions in the bolus. Direct bolus temperatures at fixed positions were taken to aim at best possible agreement between MR temperatures and these direct temperature-time curves. Then we compared additional direct temperature-position scans (thermal maps) for each experiment with the MR temperatures along these probes, which agreed satisfactorily (averaged accuracy of +/- 0.4-0.5 degrees C). The deviations decreased with decreasing observation time, temperature increase, and thermal load to the surroundings (corresponding to bolus heating)-estimating a resolution of, at best, +/- 0.2-0.3 degrees C. The acquired MR temperature distributions give also insight into limitations and control possibilities of regional hyperthermia (annular phased array technology) for various tumor sites.
CONCLUSIONS: On-line MR monitoring of regional hyperthermia by using the PFS method is feasible in a phantom setup and can be further developed for clinical applications.

Entities:  

Mesh:

Year:  2005        PMID: 15629620     DOI: 10.1016/j.ijrobp.2004.05.009

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  20 in total

1.  Hyperthermia MRI temperature measurement: evaluation of measurement stabilisation strategies for extremity and breast tumours.

Authors:  Cory Wyatt; Brian Soher; Paolo Maccarini; H Cecil Charles; Paul Stauffer; James Macfall
Journal:  Int J Hyperthermia       Date:  2009       Impact factor: 3.914

2.  Fast PRF-based MR thermometry using double-echo EPI: in vivo comparison in a clinical hyperthermia setting.

Authors:  Tetiana Dadakova; Johanna Gellermann; Otilia Voigt; Jan Gerrit Korvink; John Matthew Pavlina; Jürgen Hennig; Michael Bock
Journal:  MAGMA       Date:  2014-11-08       Impact factor: 2.310

3.  Real-time microwave imaging of differential temperature for thermal therapy monitoring.

Authors:  Mark Haynes; John Stang; Mahta Moghaddam
Journal:  IEEE Trans Biomed Eng       Date:  2014-06       Impact factor: 4.538

4.  A heterogeneous human tissue mimicking phantom for RF heating and MRI thermal monitoring verification.

Authors:  Yu Yuan; Cory Wyatt; Paolo Maccarini; Paul Stauffer; Oana Craciunescu; James Macfall; Mark Dewhirst; Shiva K Das
Journal:  Phys Med Biol       Date:  2012-03-20       Impact factor: 3.609

5.  Accuracy of real time noninvasive temperature measurements using magnetic resonance thermal imaging in patients treated for high grade extremity soft tissue sarcomas.

Authors:  Oana I Craciunescu; Paul R Stauffer; Brian J Soher; Cory R Wyatt; Omar Arabe; Paolo Maccarini; Shiva K Das; Kung-Shan Cheng; Terence Z Wong; Ellen L Jones; Mark W Dewhirst; Zeljko Vujaskovic; James R MacFall
Journal:  Med Phys       Date:  2009-11       Impact factor: 4.071

Review 6.  Heating technology for malignant tumors: a review.

Authors:  H Petra Kok; Erik N K Cressman; Wim Ceelen; Christopher L Brace; Robert Ivkov; Holger Grüll; Gail Ter Haar; Peter Wust; Johannes Crezee
Journal:  Int J Hyperthermia       Date:  2020       Impact factor: 3.914

7.  Vesicoureteral reflux in children: a phantom study of microwave heating and radiometric thermometry of pediatric bladder.

Authors:  Yngve Birkelund; Øystein Klemetsen; Svein K Jacobsen; Kavitha Arunachalam; Paolo Maccarini; Paul R Stauffer
Journal:  IEEE Trans Biomed Eng       Date:  2011-09-06       Impact factor: 4.538

Review 8.  Catheter-based ultrasound technology for image-guided thermal therapy: current technology and applications.

Authors:  Vasant A Salgaonkar; Chris J Diederich
Journal:  Int J Hyperthermia       Date:  2015-03-23       Impact factor: 3.914

Review 9.  Overview of bladder heating technology: matching capabilities with clinical requirements.

Authors:  Paul R Stauffer; Gerard C van Rhoon
Journal:  Int J Hyperthermia       Date:  2016-03-04       Impact factor: 3.914

10.  Model-based feasibility assessment and evaluation of prostate hyperthermia with a commercial MR-guided endorectal HIFU ablation array.

Authors:  Vasant A Salgaonkar; Punit Prakash; Viola Rieke; Eugene Ozhinsky; Juan Plata; John Kurhanewicz; I-C Joe Hsu; Chris J Diederich
Journal:  Med Phys       Date:  2014-03       Impact factor: 4.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.